MusclePharm Corporation Stock

Stocks

18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
10/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
03/10/23	Motion for Asset Sale Approved for MusclePharm Corporation	CI
27/09/23	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
08/09/23	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
01/09/23	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
28/08/23	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
28/08/23	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
17/08/23	Bidding Procedure Approved for MusclePharm Corporation	CI
19/07/23	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
19/06/23	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
26/05/23	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
12/05/23	Motion for Asset Sale Filed by MusclePharm Corporation	CI

28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
30/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/09/22	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
24/08/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	01/10/2021
Jason Keenan PRN	Corporate Officer/Principal	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
29/03/22	White Winston Select Asset Funds LLC	Sell	Company	626,826	1.8775%
21/12/21	Sabina Rizvi	Free	Chairperson	1,811,000	5.4244%
01/04/21	Sabina Rizvi	Other	President & CFO	0	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MUSCLEPHARM CORPORATION	-.--%	-.--%	-	-	33
EINRIDE AB	-10.64%	+11.06%	-	-	1.21B
CHURCHILL CAPITAL CORP XI	-2.23%	+42.29%	-	-	972M
CENTIEL AG	-7.67%	-23.71%	+330.46%	-67.17%	711M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.10%	-0.30%	-	-	641M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.19%	-0.29%	-	-	600M
CHURCHILL CAPITAL CORP XII	+1.31%	+3.75%	-	-	600M
CANTOR EQUITY PARTNERS IV, INC.	+0.10%	+0.48%	-	-	594M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	0.00%	+3.41%	-	-	585M
Average	-1.98%	+12.96%	+330.46%	-67.17%	739.22M
Weighted average by Cap.	-3.16%	+18.67%	+330.46%	-67.17%